AR216479A1 - Procedimiento para preparar una composicion farmaceutica de liberacion controlada y sostenida de 4-(2-hidroxi-3-alquil (c1-c4)-aminopropoxi)-indol - Google Patents

Procedimiento para preparar una composicion farmaceutica de liberacion controlada y sostenida de 4-(2-hidroxi-3-alquil (c1-c4)-aminopropoxi)-indol

Info

Publication number
AR216479A1
AR216479A1 AR268575A AR26857577A AR216479A1 AR 216479 A1 AR216479 A1 AR 216479A1 AR 268575 A AR268575 A AR 268575A AR 26857577 A AR26857577 A AR 26857577A AR 216479 A1 AR216479 A1 AR 216479A1
Authority
AR
Argentina
Prior art keywords
aminopropoxi
indole
sustained
hydroxy
alkyl
Prior art date
Application number
AR268575A
Other languages
English (en)
Spanish (es)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of AR216479A1 publication Critical patent/AR216479A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR268575A 1976-07-27 1977-07-27 Procedimiento para preparar una composicion farmaceutica de liberacion controlada y sostenida de 4-(2-hidroxi-3-alquil (c1-c4)-aminopropoxi)-indol AR216479A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (1)

Publication Number Publication Date
AR216479A1 true AR216479A1 (es) 1979-12-28

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
AR268575A AR216479A1 (es) 1976-07-27 1977-07-27 Procedimiento para preparar una composicion farmaceutica de liberacion controlada y sostenida de 4-(2-hidroxi-3-alquil (c1-c4)-aminopropoxi)-indol

Country Status (27)

Country Link
JP (1) JPS5315411A (sv)
AR (1) AR216479A1 (sv)
AT (1) AT369987B (sv)
AU (1) AU515738B2 (sv)
BE (1) BE857122A (sv)
CA (1) CA1095833A (sv)
CY (1) CY1261A (sv)
DE (1) DE2732335C2 (sv)
DK (1) DK325677A (sv)
ES (1) ES461020A1 (sv)
FI (1) FI772217A (sv)
FR (1) FR2359607A1 (sv)
GB (1) GB1589982A (sv)
GR (1) GR65014B (sv)
HK (1) HK81884A (sv)
HU (1) HU178340B (sv)
IE (1) IE45534B1 (sv)
IL (1) IL52587A (sv)
KE (1) KE3441A (sv)
MY (1) MY8400057A (sv)
NL (1) NL176227C (sv)
NO (1) NO149874C (sv)
NZ (1) NZ184722A (sv)
PT (1) PT66850B (sv)
SE (1) SE437469B (sv)
SG (1) SG53884G (sv)
ZA (1) ZA774536B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (sv) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
SE437469B (sv) 1985-03-04
CA1095833A (en) 1981-02-17
NL176227C (nl) 1985-03-18
FR2359607B1 (sv) 1980-02-22
NO149874B (no) 1984-04-02
KE3441A (en) 1984-09-14
PT66850A (fr) 1977-08-01
AU2730177A (en) 1979-02-01
ATA541377A (de) 1982-07-15
DK325677A (da) 1978-01-28
GB1589982A (en) 1981-05-20
BE857122A (fr) 1978-01-25
FI772217A (sv) 1978-01-28
PT66850B (fr) 1979-03-13
HK81884A (en) 1984-11-25
NO149874C (no) 1984-07-11
AU515738B2 (en) 1981-04-30
ES461020A1 (es) 1979-05-01
NZ184722A (en) 1980-10-24
DE2732335A1 (de) 1978-02-02
DK325877A (da) 1978-01-20
NO772575L (no) 1978-01-30
MY8400057A (en) 1984-12-31
IL52587A0 (en) 1977-10-31
FR2359607A1 (fr) 1978-02-24
DE2732335C2 (de) 1983-01-20
NL176227B (nl) 1984-10-16
AT369987B (de) 1983-02-25
IE45534B1 (en) 1982-09-22
ZA774536B (en) 1979-02-28
SG53884G (en) 1985-03-08
IL52587A (en) 1980-09-16
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
NL7708162A (nl) 1978-01-31
JPS5315411A (en) 1978-02-13
GR65014B (en) 1980-06-13
JPS5726650B2 (sv) 1982-06-05
SE7708265L (sv) 1978-01-28
CY1261A (en) 1984-11-23

Similar Documents

Publication Publication Date Title
MX4035E (es) Procedimiento para preparar una 4-(5 0 7) benzoilindolin-2-ona
DK92378A (da) Substituerede phenoxybenzyloxycarbonylderivater fremgangsmaade til deres femstilling og deres anvendelse som insecticider og acaricider
MX4469E (es) Procedimiento mejorado para obtener una composicion insecticida microencapsulada
AR226154A1 (es) Procedimiento para preparar derivados de 3-alquil(c1-c4)carbamoil-sulfonamido-4-amino-piridina y sus sales farmaceuticamente aceptables
ES489627A0 (es) Procedimiento para la obtencion de derivados de tetrahidro- piridina y piperidina
DK240475A (da) Thiopolymere deres derivater og fremgangsmader til deres fremstilling og brug
ES497403A0 (es) Procedimiento para preparar una composicion estable de s- adenosil-l-metionina
AR216479A1 (es) Procedimiento para preparar una composicion farmaceutica de liberacion controlada y sostenida de 4-(2-hidroxi-3-alquil (c1-c4)-aminopropoxi)-indol
AR207727A1 (es) Procedimiento y dispositivo para la preparacion de una mezcla particularmente una mezcla fraguable para la construccion
DK352477A (da) 1-azolyl-4-hydroxy-butan-derivater fremgangsmade til deres fremstilling og deres anvendelse som fungicider og bactericider
AR217240A1 (es) Procedimiento para preparar derivados acilamino sustituidos de 1,2,4-oxadiazol,1,3-4-oxadiazol,1,2,4-tiadiazol y 1,3,4-tiadiazol,terapeuticamente utiles
BE861141A (fr) Preparations pharmaceutiques a liberation soutenue des substances actives
AR216043A1 (es) Procedimiento para la preparacion de 1-derivados de benzoilamino-4-piperidina y sus sales fisiologicamente aceptables
DK354777A (da) N-sulfenylerede oximcarbamater fremgangsmade til deres fremstilling og deres anvendelse som insecticider acaricider og nematodicider
AR213184A1 (es) Procedimiento para preparar derivados de 1,4-etan-6-oxo-perhidroquinoleina y sus sales
DK31576A (da) Acetylenderivater og fremgangsmade til deres fremstilling
AR216340A1 (es) Una mezcla refractaria seca y el metodo para su preparacion
DK317877A (da) Oximcarbamater af fluorerede ketoner fremgangsmade til deres fremstilling og deres anvendelse som insecticider acaricider og nematodicider
AR218452A1 (es) Procedimiento para obtener derivados de 4-(3-(4-piperidil)-propil)-quinoleina y sus sales
MX5558E (es) Procedimiento para preparar una composicion acaricida
DK132177A (da) Oximcarbamater fremgangsmade til deres fremstilling og deres anvendelse som insecticider acaricider og nematodicider
DK294579A (da) Antiprotozoelle oxadiazolderivater fremgangsmaade til deres fremstilling samt deres anvendelse
AR227759A1 (es) Procedimiento para obtener nuevos derivados de n-(4-amino-5-trialcoxi(c1-c4)-bencil)pirimidil-2-il)-alcanoilamidinas
AR215290A1 (es) Procedimiento para la preparacion de 3-(4-(2:-piridil)-piperazin-1-il)-1-(3,4,5-trimetoxi-benzoiloxi)-propano y sus sales farmaceuticamente aceptables
NO146061C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive derivater av 2-iminothiazolidiner og 2-iminothiazoliner